Institutional Ownership Mersana Therapeutics, Inc. (MRSN)
This table provides information about the institutional ownership of Mersana Therapeutics, Inc. (MRSN). We have compiled data on the 135 institutions that hold shares in the stock, with a total of 101 Million shares, which have been reported (via 13F filing form) to have a value of $38.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
795,973
shares
|
$302,469
0.0% of portfolio
|
Q4 2024
Added 206.4%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
690,272
shares
|
$262,303
0.2% of portfolio
|
Q4 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
606,285
shares
|
$230,388
0.0% of portfolio
|
Q4 2024
Added 23.05%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
544,463
shares
|
$206,895
0.0% of portfolio
|
Q4 2024
Reduced 46.75%
|
|
|
Health Invest Partners Ab
|
Feb 04, 2025 Q4 2024 |
538,621
shares
|
$204,675
0.37% of portfolio
|
Q3 2024
Added 191.3%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
508,296
shares
|
$193,152
0.05% of portfolio
|
Q4 2024
Added 87.03%
|
|
|
Clari Vest Asset Management LLC
San Diego, CA |
Nov 12, 2024 Q3 2024 |
500,498
shares
|
$190,189
0.09% of portfolio
|
Q2 2024
Added 6.07%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
448,000
shares
|
$170,240
0.0% of portfolio
|
Q4 2024
Reduced 7.97%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
435,593
shares
|
$165,525
0.0% of portfolio
|
Q4 2024
Added 0.47%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
421,360
shares
|
$160,116
0.0% of portfolio
|
Q4 2024
Reduced 90.45%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
410,029
shares
|
$155,811
0.04% of portfolio
|
Q4 2024
Reduced 28.07%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
347,415
shares
|
$132,017
0.0% of portfolio
|
Q4 2024
Reduced 60.39%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
336,806
shares
|
$127,986
0.0% of portfolio
|
Q4 2024
Reduced 74.16%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
312,623
shares
|
$118,796
0.0% of portfolio
|
Q3 2024
Reduced -0.0%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Feb 13, 2025 Q4 2024 |
239,685
shares
|
$91,080
0.0% of portfolio
|
Q4 2024
Added 2.78%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
232,223
shares
|
$88,244
0.0% of portfolio
|
Q4 2024
Added 53.59%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
210,876
shares
|
$80,132
0.0% of portfolio
|
Q4 2024
Reduced 29.76%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Feb 12, 2025 Q4 2024 |
194,153
shares
|
$73,778
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
186,060
shares
|
$70,702
0.0% of portfolio
|
Q2 2024
Added 10.22%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
183,723
shares
|
$69,814
0.0% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
182,711
shares
|
$69,430
0.0% of portfolio
|
Q4 2024
Reduced 63.05%
|
|
|
Exome Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
172,924
shares
|
$65,711
0.19% of portfolio
|
Q4 2024
Reduced 85.33%
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
171,857
shares
|
$65,305
0.0% of portfolio
|
Q4 2024
Added 3.0%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
162,264
shares
|
$61,660
0.0% of portfolio
|
Q4 2024
Reduced 65.73%
|
|
|
Los Angeles Capital Management LLC
|
Feb 04, 2025 Q4 2024 |
159,760
shares
|
$60,708
0.0% of portfolio
|
Q4 2024
Reduced 15.77%
|